- Work address
-
C. Heymanslaan 10, ingang 38 (MRB2)
9000 Gent - Tom.Taghon@UGent.be
- ORCID iD
-
0000-0002-5781-0288
Show
Sort by
-
- Journal Article
- A1
- open access
Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials
-
- Journal Article
- A1
- open access
A DL-4-and TNF alpha-based culture system to generate high numbers of nonmodified or genetically modified immunotherapeutic human T-lymphoid progenitors
-
- Journal Article
- A1
- open access
Thymic epithelial cell alterations and defective thymopoiesis lead to central and peripheral tolerance perturbation in MHCII deficiency
-
- Journal Article
- A1
- open access
Modeling of human T cell development in vitro as a read-out for hematopoietic stem cell multipotency
-
- Journal Article
- A1
- open access
In vitro OP9-DL1 co-culture and subsequent maturation in the presence of IL-21 generates tumor antigen-specific T cells with a favorable less-differentiated phenotype and enhanced functionality
-
- Journal Article
- A1
- open access
T-BET and EOMES accelerate and enhance functional differentiation of human natural killer cells
-
- Journal Article
- A1
- open access
A novel non-coding variant in DCLRE1C results in deregulated splicing and induces SCID through the generation of a truncated ARTEMIS protein that fails to support V(D)J recombination and DNA damage repair
-
The RNA Atlas expands the catalog of human non-coding RNAs
-
A tumor suppressor enhancer of PTEN in T-cell development and leukemia
-
PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis